Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 2
1999 3
2000 2
2001 2
2002 3
2003 2
2004 1
2005 4
2006 3
2007 1
2008 4
2009 6
2010 7
2011 3
2012 11
2013 8
2014 8
2015 5
2016 5
2017 6
2018 3
2019 6
2020 2
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Results by year
Filters applied: . Clear all
Page 1
The diabetes prevention program.
Adler AI, Turner RC. Adler AI, et al. Diabetes Care. 1999 Apr;22(4):543-5. doi: 10.2337/diacare.22.4.543. Diabetes Care. 1999. PMID: 10189529 Review. No abstract available.
Ocrelizumab for primary progressive multiple sclerosis.
Adler AI, Knight H. Adler AI, et al. Lancet Neurol. 2019 Sep;18(9):816-817. doi: 10.1016/S1474-4422(19)30245-5. Epub 2019 Jul 3. Lancet Neurol. 2019. PMID: 31279744 No abstract available.
Micronutrients and diabetic retinopathy a systematic review.
Lee CT, Gayton EL, Beulens JW, Flanagan DW, Adler AI. Lee CT, et al. Among authors: adler ai. Ophthalmology. 2010 Jan;117(1):71-8. doi: 10.1016/j.ophtha.2009.06.040. Epub 2009 Nov 8. Ophthalmology. 2010. PMID: 19900709 Review.
NICE guidance on sotagliflozin for type 1 diabetes.
Adler AI, Cronshaw J, Prescott C, Patel S, Donegan E, Hayre J. Adler AI, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):274-275. doi: 10.1016/S2213-8587(20)30066-8. Epub 2020 Feb 24. Lancet Diabetes Endocrinol. 2020. PMID: 32105642 No abstract available.
102 results